当前位置: 首页 > 期刊 > 《世界中医药》 > 2023年第2期
编号:214830
从《黄帝内经》痹证理论探讨硬皮病的病机与治疗
http://www.100md.com 2023年6月23日 世界中医药 2023年第2期
     王瑞洁 姜文琦 张润田 段行武 陈曦

    摘要 硬皮病属于中医“痹证”的范畴,《黄帝内经》中对痹证定义、分类、病因病机、治疗及预后的阐述,为痹证类疾病的诊治奠定了理论基础。本文论证硬皮病所属的痹证范畴可囊括《黄帝内经》中各类五体痹、五脏痹等,以《黄帝内经》痹证理论为指导,结合硬皮病的临床表现和现代病理机制,从邪、虚、瘀和疾病传变等角度,探讨硬皮病的中医病机与治疗。

    关键词 黄帝内经;硬皮病;痹证;皮痹;五体痹;五脏痹;中医药;治未病

    Pathogenesis and Treatment of Scleroderma from the Theory of Impediment Syndrome in The Yellow Emperor′s Inner Classic

    WANG Ruijie,JIANG Wenqi,ZHANG Runtian,DUAN Xingwu,CHEN Xi

    (Dongzhimen Hospital,Beijing University of Chinese Medicine,Beijing 100700,China)

    Abstract Scleroderma belongs to the category of “impediment syndrome” in traditional Chinese medicine.The definition,classification,etiology,pathogenesis,treatment,and prognosis of impediment syndrome in The Yellow Emperor′s Inner Classic have laid a theoretical foundation for diagnosis and treatment to impediment syndrome.This paper demonstrated that scleroderma belonged to the category of impediment syndrome,which included all kinds of five-body constituent impediment syndrome and five zang-organ impediment syndrome in The Yellow Emperor′s Inner Classic.Guided by the impediment syndrome theory in The Yellow Emperor′s Inner Classic ......

您现在查看是摘要页,全文长 18239 字符